Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03035890 · ClinicalTrials.gov registry record · NA
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
A NA study, sponsored by West Virginia University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03035890 is a NA study that has completed, run by West Virginia University. The registered enrollment target is 35 participants.
The verdict
NCT03035890, a NA study, has completed, sponsored by West Virginia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study includes the additional use of radiation therapy in combination immunotherapy in order to determine whether the radiation may improve the response of non-small cell lung cancer to immunotherapy and to monitor any side effects.
Interventions
- RADIATION Radiation
- DRUG Immuno-Therapeutic Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-01-23 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03035890
The ClinicalTrials.gov registry entry for NCT03035890 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiation is the first listed.
NCT03035890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03035890 about?
NCT03035890 is a clinical study titled "Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer". This study includes the additional use of radiation therapy in combination immunotherapy in order to determine whether the radiation may improve the response of non-small cell lung cancer to immunotherapy and to monitor any side effects.
What is the current status of trial NCT03035890?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-01-23. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03035890?
The interventions under investigation include: Radiation (RADIATION), Immuno-Therapeutic Agent (DRUG).
Who is sponsoring clinical trial NCT03035890?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.